PubRank

Timo Sorsa

Author PubWeight™ 139.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler Thromb Vasc Biol 2007 2.74
2 The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trial. J Am Dent Assoc 2011 2.20
3 Matrix metalloproteinase-8 (MMP-8) is the major collagenase in human dentin. Arch Oral Biol 2006 2.09
4 Gingival crevicular fluid and serum matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 levels in renal transplant patients undergoing different immunosuppressive therapy. J Clin Periodontol 2008 2.05
5 Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res 2006 1.69
6 Emdogain in carcinogenesis: a systematic review of in vitro studies. J Oral Sci 2010 1.41
7 Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. Exp Cell Res 2005 1.30
8 Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma. J Glaucoma 2005 1.25
9 Clinical changes in periodontium during pregnancy and post-partum. J Clin Periodontol 2008 1.23
10 Matrix metalloproteinases process the laminin-5 gamma 2-chain and regulate epithelial cell migration. Biochem Biophys Res Commun 2003 1.23
11 The effect of subgingival controlled-release delivery of chlorhexidine chip on clinical parameters and matrix metalloproteinase-8 levels in gingival crevicular fluid. J Periodontol 2002 1.22
12 Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women. J Periodontol 2008 1.21
13 Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines. Pharmacol Res 2011 1.21
14 Salivary biomarkers of oral health: a cross-sectional study. J Clin Periodontol 2012 1.19
15 Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13. J Biol Chem 2003 1.18
16 Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis. J Periodontal Res 2003 1.16
17 Matrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPD. Int J Chron Obstruct Pulmon Dis 2007 1.15
18 Salivary biomarkers for detection of systemic diseases. PLoS One 2013 1.13
19 Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis. J Clin Periodontol 2010 1.12
20 Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma. Lab Invest 2002 1.11
21 Use of host- and bacteria-derived salivary markers in detection of periodontitis: a cumulative approach. Dis Markers 2011 1.08
22 Complement inhibitor membrane cofactor protein (MCP; CD46) is constitutively shed from cancer cell membranes in vesicles and converted by a metalloproteinase to a functionally active soluble form. Eur J Immunol 2004 1.07
23 Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats. J Surg Res 2003 1.06
24 Activation of matrix metalloproteinase-8 by membrane type 1-MMP and their expression in human tears after photorefractive keratectomy. Invest Ophthalmol Vis Sci 2003 1.05
25 Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen. Biochemistry 2003 1.04
26 Salivary biomarkers of bacterial burden, inflammatory response, and tissue destruction in periodontitis. J Clin Periodontol 2014 1.03
27 Serum microbial- and host-derived markers of periodontal diseases: a review. Curr Med Chem 2007 1.02
28 Inhibition of matrix metalloproteinases by chemically modified tetracyclines in sepsis. Shock 2003 1.02
29 Efficacy of sub-antimicrobial dose doxycycline in post-menopausal women: clinical outcomes. J Clin Periodontol 2007 1.01
30 Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation. Pharmacol Res 2011 1.01
31 Differential Processing of {alpha}- and {beta}-Defensin Precursors by Matrix Metalloproteinase-7 (MMP-7). J Biol Chem 2009 1.01
32 Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma. Surg Oncol 2010 0.99
33 Collagenase-2 (MMP-8) and matrilysin-2 (MMP-26) expression in human wounds of different etiologies. Wound Repair Regen 2007 0.99
34 Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13/MMP-9 activation cascade. J Clin Periodontol 2009 0.99
35 Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma. ScientificWorldJournal 2013 0.97
36 Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis. Infect Immun 2008 0.97
37 A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth. Cancer Biol Ther 2009 0.96
38 Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases. Matrix Biol 2005 0.96
39 Gelatinase A (MMP-2), collagenase-2 (MMP-8), and laminin-5 gamma2-chain expression in murine inflammatory bowel disease (ulcerative colitis). Dig Dis Sci 2003 0.95
40 Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases. Periodontol 2000 2016 0.95
41 Salivary type I collagen degradation end-products and related matrix metalloproteinases in periodontitis. J Clin Periodontol 2012 0.94
42 The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis. J Periodontol 2004 0.94
43 Chemically modified tetracycline (CMT-8) and estrogen promote wound healing in ovariectomized rats: effects on matrix metalloproteinase-2, membrane type 1 matrix metalloproteinase, and laminin-5 gamma2-chain. Wound Repair Regen 2002 0.94
44 Determination of matrix metalloproteinases in human radicular dentin. J Endod 2009 0.94
45 Association of gingival crevicular fluid biomarkers during periodontal maintenance with subsequent progressive periodontitis. J Periodontol 2010 0.93
46 Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines. Anticancer Drugs 2002 0.92
47 Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis. J Clin Periodontol 2014 0.92
48 Stabilization of the activated alphaMbeta2 integrin by a small molecule inhibits leukocyte migration and recruitment. Biochemistry 2006 0.91
49 Trypsins and their role in carcinoma growth. Exp Cell Res 2006 0.91
50 Effect of decreased loading on the metabolic activity of the mandibular condylar cartilage in the rat. Eur J Orthod 2004 0.91
51 Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease. J Periodontol 2006 0.91
52 Characteristics of collagenase-2 from gingival crevicular fluid and peri-implant sulcular fluid in periodontitis and peri-implantitis patients: pilot study. Acta Odontol Scand 2008 0.91
53 Factors affecting matrix metalloproteinase-8 levels in the vaginal and cervical fluids in the first and second trimester of pregnancy. Hum Reprod 2009 0.90
54 Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma. Head Neck 2014 0.90
55 Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma. J Glaucoma 2006 0.89
56 Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood. Inflammation 2009 0.89
57 Gingival crevicular fluid MMP-8 and -13 and TIMP-1 levels in patients with rheumatoid arthritis and inflammatory periodontal disease. J Periodontol 2009 0.89
58 Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis. APMIS 2002 0.89
59 Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid. J Periodontal Res 2003 0.88
60 Prognostic significance of matrix metalloproteinase-2, -8, -9, and -13 in oral tongue cancer. J Oral Pathol Med 2011 0.87
61 Immunolocalization of EMMPRIN (CD147) in the human eye and detection of soluble form of EMMPRIN in ocular fluids. Curr Eye Res 2006 0.87
62 Urinary matrix metalloproteinase -8, -9, -14 and their regulators (TRY-1, TRY-2, TATI) in patients with diabetic nephropathy. Ann Med 2008 0.87
63 Metalloproteinase function in chronic rhinosinusitis with nasal polyposis. Laryngoscope 2007 0.87
64 Acute myocardial infarction is reflected in salivary matrix metalloproteinase-8 activation level. J Periodontol 2010 0.87
65 Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma. Exp Cell Res 2007 0.87
66 Role of matrix metalloproteinases in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol 2008 0.86
67 Gingival crevicular fluid matrix metalloproteinase-25 and -26 levels in periodontal disease. J Periodontol 2006 0.86
68 Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma. Melanoma Res 2008 0.86
69 Smoking affects diagnostic salivary periodontal disease biomarker levels in adolescents. J Periodontol 2010 0.85
70 Predictive value of cerebrospinal fluid matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 concentrations in childhood bacterial meningitis. Pediatr Infect Dis J 2014 0.85
71 Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP. Cancer Invest 2012 0.85
72 Serum and salivary matrix metalloproteinases, neutrophil elastase, myeloperoxidase in patients with chronic or aggressive periodontitis. Inflammation 2014 0.84
73 Inhibition of matrix metalloproteinase-14 in osteosarcoma cells by clodronate. J Surg Res 2003 0.84
74 Human beta-defensin-1 and -2 and matrix metalloproteinase-25 and -26 expression in chronic and aggressive periodontitis and in peri-implantitis. Arch Oral Biol 2007 0.84
75 Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy. J Periodontol 2002 0.84
76 Trypsin-2 degrades human type II collagen and is expressed and activated in mesenchymally transformed rheumatoid arthritis synovitis tissue. Am J Pathol 2005 0.83
77 Matrix metalloproteinase-1 and -8 in gingival crevicular fluid during orthodontic tooth movement: a pilot study during 1 month of follow-up after fixed appliance activation. Eur J Orthod 2005 0.83
78 Tear fluid levels of MMP-8 are elevated in ocular rosacea--treatment effect of oral doxycycline. Graefes Arch Clin Exp Ophthalmol 2006 0.83
79 The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence. Int J Cardiol 2012 0.83
80 Associations of periodontal microorganisms with salivary proteins and MMP-8 in gingival crevicular fluid. J Clin Periodontol 2011 0.83
81 Matrix-metalloproteinase-2, -8 and -9 in serum and skin blister fluid in patients with severe sepsis. Crit Care 2010 0.83
82 Serum MMP-8 levels increase in colorectal cancer and correlate with disease course and inflammatory properties of primary tumors. Int J Cancer 2011 0.83
83 Doxycycline [corrected] inhibits mononuclear cell-mediated connective tissue breakdown. FEMS Immunol Med Microbiol 2009 0.83
84 Up-regulation of trypsin and mesenchymal MMP-8 during development of hyperoxic lung injury in the rat. Pediatr Res 2006 0.83
85 Assessment of systemic matrix metalloproteinase and their regulator response in children with Helicobacter pylori gastritis. Scand J Clin Lab Invest 2010 0.83
86 Type I and III collagen degradation products in serum predict patient survival in head and neck squamous cell carcinoma. Oral Oncol 2011 0.82
87 Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate. J Periodontol 2007 0.82
88 Clinical findings, bronchoalveolar lavage fluid cytology and matrix metalloproteinase-2 and -9 in canine pulmonary eosinophilia. Vet J 2002 0.82
89 Experimental tooth pain elevates substance P and matrix metalloproteinase-8 levels in human gingival crevice fluid. Acta Odontol Scand 2008 0.81
90 Matrix metalloproteinase-8/collagenase-2 in childhood otitis media with effusion. Ann Med 2010 0.81
91 Lack of MMP-9 expression is a marker for poor prognosis in Dukes' B colorectal cancer. BMC Clin Pathol 2012 0.81
92 The effects of selective COX-2 inhibitor/celecoxib and omega-3 fatty acid on matrix metalloproteinases, TIMP-1, and laminin-5gamma2-chain immunolocalization in experimental periodontitis. J Periodontol 2008 0.81
93 Effect of MMP-1 promoter polymorphisms on GCF MMP-1 levels and outcome of periodontal therapy in patients with severe chronic periodontitis. J Clin Periodontol 2008 0.81
94 Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer. Oral Oncol 2010 0.81
95 Prognostic value of serum MMP-8, -9 and TIMP-1 in patients with hepatocellular carcinoma. Ann Med 2013 0.81
96 The association of serum neutrophil markers and acute coronary syndrome. Scand J Immunol 2012 0.81
97 Combining salivary pathogen and serum antibody levels improves their diagnostic ability in detection of periodontitis. J Periodontol 2013 0.81
98 AlphaMbeta2 integrin modulator exerts antitumor activity in vivo. Anticancer Res 2008 0.80
99 Human tongue carcinoma growth is inhibited by selective antigelatinolytic peptides. Int J Cancer 2006 0.80
100 Periodontal status and neutrophilic enzyme levels in gingival crevicular fluid during pregnancy and postpartum. J Periodontol 2010 0.80
101 Laminin-5 gamma 2 chain is colocalized with gelatinase-A (MMP-2) and collagenase-3 (MMP-13) in odontogenic keratocysts. J Oral Pathol Med 2003 0.80
102 Tear fluid concentration of mmp-8 is elevated in non-allergic eosinophilic conjunctivitis and correlates with conjunctival inflammatory cell infiltration. Graefes Arch Clin Exp Ophthalmol 2009 0.80
103 MMP activation in diagnostics of periodontitis and systemic inflammation. J Clin Periodontol 2011 0.80
104 Pulmonary trypsin-2 in the development of bronchopulmonary dysplasia in preterm infants. Pediatrics 2003 0.80
105 Healing of extraction sockets in collagenase-2 (matrix metalloproteinase-8)-deficient mice. Eur J Oral Sci 2009 0.80
106 Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel disease. Scand J Gastroenterol 2012 0.80
107 The effects of Candida proteinases on human proMMP-9, TIMP-1 and TIMP-2. Mycoses 2010 0.80
108 The effect of prolonged systemic doxycycline therapy on serum tissue degrading proteinases in coronary bypass patients: a randomized, double-masked, placebo-controlled clinical trial. Inflamm Res 2013 0.79
109 Gingival crevicular fluid matrix metalloproteinase-8 levels predict treatment outcome among smokers with chronic periodontitis. J Periodontol 2013 0.79
110 Serum MMP-8 and TIMP-1 in critically ill patients with acute respiratory failure: TIMP-1 is associated with increased 90-day mortality. Anesth Analg 2014 0.79
111 Azithromycin as an adjunctive treatment of generalized severe chronic periodontitis: clinical, microbiologic, and biochemical parameters. J Periodontol 2012 0.79
112 Altered expression of matrix metalloproteinases and their tissue inhibitors as possible contributors to corneal droplet formation in climatic droplet keratopathy. Acta Ophthalmol 2009 0.79
113 Cell-cell contact activation of fibroblasts increases the expression of matrix metalloproteinases. Ann Med 2006 0.79
114 Proteolytic Activities of Oral Bacteria on ProMMP-9 and the Effect of Synthetic Proteinase Inhibitors. Open Dent J 2008 0.79
115 The enamel matrix derivative (Emdogain) enhances human tongue carcinoma cells gelatinase production, migration and metastasis formation. Oral Oncol 2007 0.79
116 Elevated expression and activation of matrix metalloproteinase 8 in tear fluid in atopic blepharoconjunctivitis. Cornea 2008 0.79
117 Toll-like receptors -4 and -5 in oral and cutaneous squamous cell carcinomas. J Oral Pathol Med 2014 0.79
118 Selective gelatinase inhibitor peptide is effective in targeting tongue carcinoma cell tumors in vivo. Anticancer Res 2011 0.79
119 Caries correlates strongly to salivary levels of matrix metalloproteinase-8. Caries Res 2014 0.79
120 Direct activation of gelatinase B (MMP-9) by hay dust suspension and different components of organic dust. Vet Immunol Immunopathol 2005 0.79
121 Matrix metalloproteinase-7, -8, -9, -25, and -26 and CD43, -45, and -68 cell-markers in HIV-infected patients' saliva and gingival tissue. J Oral Pathol Med 2006 0.78
122 Collagenase 2/matrix metalloproteinase 8 in critically ill patients with secondary peritonitis. Shock 2007 0.78
123 Peptides against Mac-1 do not sufficiently target leukemia or lymphoma in vivo. Anticancer Res 2014 0.78
124 Pro-inflammatory cytokines and gelatinases in climatic droplet keratopathy. Invest Ophthalmol Vis Sci 2012 0.78
125 High salivary estrogen and risk of developing pregnancy gingivitis. J Periodontol 2012 0.78
126 Matrix metalloproteinase (MMP)-8 and tissue inhibitor of MMP-1 (TIMP-1) gene polymorphisms in generalized aggressive periodontitis: gingival crevicular fluid MMP-8 and TIMP-1 levels and outcome of periodontal therapy. J Periodontol 2013 0.78
127 Arresten, a collagen-derived angiogenesis inhibitor, suppresses invasion of squamous cell carcinoma. PLoS One 2012 0.78
128 Collagenases in gingival crevicular fluid in type 1 diabetes mellitus. J Periodontol 2006 0.78
129 Inhibition of smooth muscle cell proliferation by a chemically modified tetracycline. Coron Artery Dis 2007 0.78
130 Local and systemic proteolytic responses in chronic rhinosinusitis with nasal polyposis and asthma. Int Forum Allergy Rhinol 2015 0.78
131 Levels of matrix metalloproteinase-2, -9 and -8 in the skin, serum and saliva of smokers and non-smokers. Arch Dermatol Res 2005 0.78
132 The effect of smoking on periodontal health of 15- to 16-year-old adolescents. J Periodontol 2008 0.78
133 The effect of adjunctive chlorhexidine mouthrinse on GCF MMP-8 and TIMP-1 levels in gingivitis: a randomized placebo-controlled study. BMC Oral Health 2014 0.77
134 Cellular fibronectin in failing dental implants. Int J Oral Maxillofac Implants 2002 0.77
135 Matrix metalloproteinase-8 in cervical fluid in early and mid pregnancy: relation to spontaneous preterm delivery. Prenat Diagn 2010 0.77
136 The effect of adjunctive subantimicrobial dose doxycycline therapy on GCF EMMPRIN levels in chronic periodontitis. J Periodontol 2008 0.77
137 Safety issues of Lactobacillus bulgaricus with respect to human gelatinases in vitro. FEMS Immunol Med Microbiol 2007 0.77
138 Subantimicrobial-dose doxycycline treatment increases serum cholesterol efflux capacity from macrophages. Inflamm Res 2013 0.77
139 MMP-13 promoter polymorphisms in patients with chronic periodontitis: effects on GCF MMP-13 levels and outcome of periodontal therapy. J Clin Periodontol 2009 0.77
140 Pregnancy-induced gingivitis and OMICS in dentistry: in silico modeling and in vivo prospective validation of estradiol-modulated inflammatory biomarkers. OMICS 2014 0.77
141 Combination treatment in Chlamydia-triggered reactive arthritis: comment on the article by Carter et al. Arthritis Rheum 2011 0.77
142 Chemically modified tetracyclines induce apoptosis in cultured mast cells. Int Immunopharmacol 2005 0.76
143 Effectiveness of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid laminin-5 gamma2 chain levels in chronic periodontitis. J Periodontol 2004 0.76
144 Serum matrix metalloproteinases in patients resuscitated from cardiac arrest. The association with therapeutic hypothermia. Resuscitation 2011 0.76
145 In vitro inhibition of matrix metalloproteinase activity in tracheal epithelial lining fluid from horses with recurrent airway obstruction. Am J Vet Res 2006 0.76
146 Epithelial and stromal syndecan-1 and -2 are distinctly expressed in oral- and cutaneous squamous cell carcinomas. J Oral Pathol Med 2012 0.76
147 Letter to the Editor concerning "Emdogain(®) in carcinogenesis: a systematic review of in vitro studies" by Laaksonen M, Sorsa T, Salo T (2010) J Oral Sci 52, 1-11. J Oral Sci 2010 0.75
148 Osteoarthritis: linking nitric oxide and metalloproteinases in canine articular ligament pathology. Vet J 2005 0.75
149 A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro. PLoS One 2014 0.75
150 Gingival crevicular fluid laminin-5 gamma2-chain levels in periodontal disease. J Clin Periodontol 2006 0.75
151 Collagen degradation by tumor-associated trypsins. Arch Biochem Biophys 2013 0.75
152 By mistakes we learn: determination of matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 in serum yields doubtful results. J Clin Periodontol 2008 0.75
153 In vivo targeting of activated leukocytes by a β2-integrin binding peptide. Mol Diagn Ther 2014 0.75
154 Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines. Ann Med 2005 0.75
155 Single nucleotide polymorphism -799C/T in matrix metalloproteinase-8 promoter region in arterial disease. Innate Immun 2011 0.75
156 Collagenolytic activity in bronchoalveolar lavage fluid in canine pulmonary eosinophilia. J Vet Intern Med 2002 0.75
157 A chimera of green fluorescent protein with gelatinase binding and tumor targeting peptide. Protein Expr Purif 2010 0.75
158 Evaluation of systemic levels of neutrophilic enzymes in patients with hypertension and chronic periodontitis. J Periodontol 2013 0.75
159 Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels. Cancer Immunol Immunother 2014 0.75
160 Matrix metalloproteinase -2, -8, -9, and -13 in gingival crevicular fluid of short root anomaly patients. Eur J Orthod 2003 0.75
161 GCF and serum myeloperoxidase and matrix metalloproteinase-13 levels in renal transplant patients. Arch Oral Biol 2010 0.75
162 Direct evidence of collagenolysis in chronic periodontitis. J Periodontal Res 2003 0.75
163 Chemically modified tetracycline improves contractility in porcine coronary ischemia/reperfusion injury. J Card Surg 2006 0.75
164 Inhibition of gelatinase activity by cyclic peptides--A support for oral cancer treatment? Oral Oncol 2006 0.75
165 [Tobacco, snuff and oral health]. Duodecim 2015 0.75
166 Herpes viruses lack association with acute parotitis in children. Pediatr Infect Dis J 2011 0.75